NFE2L2 and cancer: We surmise that as NRF2-activated cancer cells have an ability to suppress immune cell infiltration into tumors, circulating immune cells tend to accumulate more in WT 3LL tumors than in KEAP1-KO 3LL tumors in the bilateral model.